After a deceased woman's toxicology report showed an abnormality — a chemical compound found in several brands of over-the-counter eye drops — suspicions grow over her caregiver's story.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.